Dr. Emily Tylski, DO
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $6,000 | 2 | 76.1% |
| Travel and Lodging | $964.66 | 3 | 12.2% |
| Food and Beverage | $920.24 | 43 | 11.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $6,982 | 6 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $210.08 | 11 | $0 (2024) |
| GENZYME CORPORATION | $172.01 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $101.09 | 3 | $0 (2024) |
| Amgen Inc. | $91.73 | 4 | $0 (2024) |
| Grifols USA, LLC | $62.17 | 3 | $0 (2024) |
| Mylan Specialty L.P. | $54.56 | 3 | $0 (2024) |
| Axsome Therapeutics, Inc. | $31.24 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $21.43 | 1 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $20.57 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $456.70 | 19 | GENZYME CORPORATION ($114.27) |
| 2023 | $7,273 | 21 | Intuitive Surgical, Inc. ($6,982) |
| 2022 | $139.55 | 7 | AstraZeneca Pharmaceuticals LP ($46.19) |
| 2018 | $16.01 | 1 | Mallinckrodt LLC ($16.01) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Pulmonology | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Respiratory | ||||||
| 07/30/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Inflammation | ||||||
| 07/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.34 | General |
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Immunology | ||||||
| 06/20/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/29/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Neurology | ||||||
| 03/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Immunology | ||||||
| 02/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.12 | General |
| Category: Immunology | ||||||
| 02/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
| 01/03/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Respiratory | ||||||
| 11/15/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/21/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: Immunology | ||||||
| 09/05/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 08/31/2023 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Infectious Diseases | ||||||
| 08/26/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $452.32 | General |
| Category: SURGERY | ||||||
| 08/24/2023 | Intuitive Surgical, Inc. | ION (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 348 | 538 | $144,604 | $55,796 |
| 2022 | 13 | 535 | 686 | $175,919 | $60,393 |
| 2021 | 14 | 646 | 835 | $278,352 | $70,474 |
| 2020 | 12 | 298 | 401 | $129,022 | $34,249 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 61 | 156 | $68,172 | $25,321 | 37.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 69 | 126 | $25,200 | $11,564 | 45.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 84 | $11,676 | $5,155 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 53 | $10,812 | $4,750 | 43.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $13,314 | $4,199 | 31.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 24 | $9,360 | $3,216 | 34.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $2,926 | $1,053 | 36.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 12 | $1,092 | $207.28 | 19.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 11 | 12 | $1,260 | $190.99 | 15.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 18 | 18 | $792.00 | $138.98 | 17.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 57 | 131 | $64,222 | $22,011 | 34.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 51 | $19,530 | $7,709 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 72 | $15,403 | $6,591 | 42.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 69 | 119 | $18,153 | $6,519 | 35.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 50 | 63 | $14,175 | $4,956 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $9,216 | $3,411 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 31 | $4,338 | $1,797 | 41.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $4,402 | $1,744 | 39.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 40 | 40 | $6,920 | $1,711 | 24.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 38 | 38 | $6,042 | $1,513 | 25.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 27 | 34 | $2,912 | $975.45 | 33.5% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 35 | 35 | $3,990 | $941.32 | 23.6% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 15 | 15 | $6,311 | $437.79 | 6.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 11 | 11 | $305.00 | $75.93 | 24.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 59 | 159 | $116,388 | $25,923 | 22.3% |
About Dr. Emily Tylski, DO
Dr. Emily Tylski, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2014. The National Provider Identifier (NPI) number assigned to this provider is 1740608546.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emily Tylski, DO has received a total of $7,885 in payments from pharmaceutical and medical device companies, with $456.70 received in 2024. These payments were reported across 48 transactions from 18 companies. The most common payment nature is "Education" ($6,000).
As a Medicare-enrolled provider, Tylski has provided services to 1,827 Medicare beneficiaries, totaling 2,460 services with total Medicare billing of $220,911. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Pulmonary Disease
- Location Kansas City, MO
- Active Since 03/31/2014
- Last Updated 08/19/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740608546
Products in Payments
- Da Vinci Surgical System (Device) $3,982
- ION (Device) $3,000
- DUPIXENT (Biological) $273.10
- FASENRA (Biological) $109.73
- TEZSPIRE (Biological) $106.45
- Prolastin-C Liquid (Biological) $62.17
- YUPELRI (Drug) $54.56
- BREZTRI (Drug) $33.23
- Sunosi (Drug) $31.24
- ZERBAXA (Drug) $21.43
- XYWAV (Drug) $20.57
- AIRSUPRA (Drug) $20.24
- ACTHAR (Biological) $19.83
- Hillrom - Life 2000 Ventilation System (Device) $18.93
- Xolair (Biological) $18.36
- Cresemba (Drug) $18.25
- Arikayce (Drug) $16.38
- CHARTIS CATHETER (Device) $15.27
- CALQUENCE (Drug) $12.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Kansas City
Rigoberto Ramirez, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $63,148
Peter Lau, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $17,744
Syed Karim, M.b.b.s, M.B.B.S
Student in an Organized Health Care Education/Training Program — Payments: $15,513
Jennifer Buckley, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $12,408
Dr. Karan Josan, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $9,146
Dr. Jordyn Ginter, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $7,044